Abintus Bio, Inc. Company Profile, Contacts & Intelligence

BiotechnologySan Diego, Ca, United States7 employeesFounded 2020
2 contacts with email or phone data2 with email data2 with phone data
Employees
7
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

Abintus Bio, Inc. Overview

Driven by a bold founding vision: Empowering patients from within, Abintus is pioneering potentially curative, off-the-shelf genetic medicines that engineer cells directly inside the patient’s body, also termed in vivo. These therapies are based on Abintus' clinically proven Modular Delivery Platform (MDP). The company’s two initial, fit-for-purpose, In Vivo programs are: 1. Highly selective gene expression targeting cell type/state via synthetic biology (e.g., In Vivo CAR-NK/T/Treg, In Vivo TCR-T) with applications across multiple gene delivery systems (e.g., AAV, lenti, adeno, retro) and therapeutic areas including leukemia, solid tumors, autoimmune, infectious, and genetic disease. 2. Simultaneous engineering of a diverse repertoire of active innate and adaptive immune cells (e.g., In Vivo CAR-X) with applications in diseases such as lymphoma and solid tumors. Abintus is leveraging over 20 years and $275 million of prior technology advancement for in vivo engineering including the treatment of over 350 patients through Phase 3 registration trials. Our company name comes from the Latin words “ab intus”, which means “from within”. We chose this name for 3 reasons: 1) Patients: We are pursuing product candidates that are designed to directly empower patients’ own immune cells to fight their disease from within. 2) Science: Our team is committed to scientific excellence and continual learning. Our differentiated technologies have the potential to directly reprogram activated immune cells “in situ”, or from within. 3) Culture: We believe our ability to achieve our vision will come from within - by building a performance-driven culture that prioritizes career development and rewards outstanding contributions. Abintus’ initial funding syndicate included Takeda Ventures and The Leukemia & Lymphoma Society’s Therapy Acceleration Program® (LLS TAP). Abintus Bio, Inc. (“Abintus”) is headquartered in San Diego. www.abintusbio.com.

Headquarters
San Diego, Ca, United States
Industry
Biotechnology
Founded
2020
Company Email
Available in AeroLeads

Abintus Bio, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 2 with phone data in the visible sample.

Abintus Bio, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Abintus Bio, Inc. Workforce Composition

Seniority breakdown across 3 visible profiles.

Individual contributor
2
Senior / Lead
1

Compare Similar Companies to Abintus Bio, Inc.

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Poseida Therapeutics, Inc. Biotechnology Research 218 View company
Arcturus Therapeutics Biotechnology Research 184 View company
Capstan Therapeutics Biotechnology Research 107 View company
Nitto BioPharma Biotechnology Research 36 View company
Escient Pharmaceuticals Biotechnology Research 21 View company
Abterra Biosciences Biotechnology 12 View company
Trestle Biotherapeutics Biotechnology 6 View company
Palm Therapeutics Biotechnology Research 4 View company
Endure Biotherapeutics Biotechnology Research 3 View company
Styx Biotechnologies Biotechnology Research 2 View company